Dynamics Driving OTC Markets, London
Quantifi's 2nd annual risk conference, 2014, at the historic Armourers Hall, London, attracted over 120 delegates from across the industry for a compelling afternoon of unique insights and discussion on 'The Dynamics Driving OTC Markets'

Chaired by Moorad Choudhry, Department of Mathematical Sciences, Brunel University, the conference explored the impact of regulations, the changing landscape of the OTC derivatives market with respect to valuation and risk management, the role of central clearing, and the trend towards centralised XVA desks.

Lee focussed on central clearing of OTC derivatives and the associated collateral, margin and capital requirements. He also emphasised how regulations are unbundling traditional OTC derivatives markets and consequently creating threats and opportunities for different market participants.

VIEW PRESENTATION >

Moderated by Milena Imamovic-Tomasovic, the panel reflected on the impact of market changes on XVA pricing and modelling methodology, how banks are dealing with a regulatory divergence in the market and centralised XVA processes

George Handjinicolaou, Deputy CEO, ISDA provided an overview of the structural changes to the OTC markets in response to the G20 reforms designed to reduce systemic risk and increase transparency across global financial markets. 

VIEW PRESENTATION >

“This session from Quantifi was excellent, it was very engaging, the quality of speakers was exceptional. The audience was engaged right from the beginning to the end”

Speakers

  • Prof. Moorad Choudhry, Department of Mathematical Sciences, Brunel University
  • George Handjinicolaou, Deputy CEO ISDA View presentation
  • Milena Imamovic-Tomasovic, Head of CVA, Funding & Equity Methodology, Deutsche Bank
  • Steven Marshall, MD, Cross Asset Products, Nomura
  • Jeremy Vice, MD, Head of CVA Trading, UniCredit
  • Andrew Green, Head of CVA/FVA Quantitative Research, Lloyds Banking Group
  • Lee McCormack, Executive Director, OTC Clearing, Nomura  View Presentation
  • Pierre Sarrau, MD, Blackrock
  • Ricky Maloney, Head of Buy Side Sales and Relationship Management, Eurex Clearing
  • Fiona Southall, CAIA, Senior UK LDI Solutions Manager, AXA-IM
  • Miles Courage, COO, JPS, J.P. Morgan Asset Management
  • Marshall Bailey, President, ACI International, (The Financial Markets Association)

RELATED INSIGHTS

Whitepapers

Cost of Trading and Clearing OTC Derivatives in the Wake of Margining

Over-the-counter (OTC) derivatives markets continue to be impacted by regulatory changes. These interrelated changes are affecting financial institutions and their business operations. For example, rising capital requirements are impacting profitability and return on equity market participants are now being forced to clear standard OTC derivatives trades through Central Counterparties (CCPs). Soon, there will even be margin requirements for the remaining nonstandard, uncleared derivatives (MRUDs). This is prompting firms to better assess and manage costs (funding, collateral, capital) in a consistent manner at a trade, desk and business unit level. The question is, how much of these costs can be passed on to clients?

News

Quantifi’s London Risk Conference Provides Unique Insight on ‘The Dynamics Driving OTC Markets’

Quantifi recently hosted its 2nd annual London risk conference.

Blog

Quantifi’s London Risk Conference – Transformations in the OTC Market

Senior practitioners from across the industry provide their views on the developments and key challenges facing the OTC derivatives market. Paul Lewitt, Former Global Head of Credit Trading, Lloyds Banking Group Prof. Moorad Choudhry, Department of Mathematical Sciences, Brunel University Dr. Mariam Harfush-Pardo, Market & Counterparty Risk Technical Specialist, Prudential Regulation Authority Jean-Roch Sibille, Head […]

Let's Talk!

Schedule a personalised demo today

Loading...